Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RMD | ReMed Common Stock | Options Exercise | $866K | +15K | +30.87% | $57.76 | 63.6K | Nov 22, 2022 | Direct | |
transaction | RMD | ReMed Common Stock | Sale | -$867K | -3.78K | -5.94% | $229.50 | 59.8K | Nov 22, 2022 | Direct | F1 |
transaction | RMD | ReMed Common Stock | Award | $0 | +6.92K | +11.58% | $0.00 | 66.7K | Nov 23, 2022 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RMD | ResMed Common Stock Options | Options Exercise | $0 | -15K | -100% | $0.00* | 0 | Nov 22, 2022 | ResMed Common Stock | 15K | $57.76 | Direct |
Id | Content |
---|---|
F1 | This transaction was executed in multiple trades at prices ranging from $229.42 $229.56. The price reported above reflects the weighted average sale price. |
F2 | Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on November 23, 2022, when the compensation committee certified that the performance metrics were met. |